Novaken

Guangzhou Novaken Pharmaceutical Co., Ltd. was founded in 2007. The company's main businesses include pharmaceutical formulation research and development services, high-end pharmaceutical formulation R&D, and the transfer of results. The core R&D personnel are composed of doctors and masters with backgrounds in medicine, pharmacy, and chemistry. The proportion of masters and doctors in the company exceeds 35%, and 80% of the R&D staff come from large domestic and international pharmaceutical enterprises. At the same time, well-known experts in the fields of formulation, analysis, pharmacology, clinical research, and registration have been hired to form an expert advisory committee to support the company’s R&D efforts.The company's main profit models include the PPRO model: the development of blockbuster formulations and patent product license authorization, including innovative transdermal drug delivery systems such as microneedles, high-end inhalation formulations, and high-end oral controlled-release formulations. The PCRO service model: providing customers with high-quality generic drugs, consistency evaluation, and new drug CMC R&D services through various verified patented technology platforms. Currently, Novaken's annual R&D service contracts have exceeded 100 million yuan.The company has always focused on the development of various technological platforms for innovative pharmaceutical formulations. Its core formulation technology platforms include: special oral controlled-release formulation technology platform, poorly soluble drug solubilization technology platform, transdermal microneedle formulation and industrialization technology platform, inhalation formulation technology platform, gel drug release formulation technology platform, and microsphere microcapsule industrialization technology platform.Guangzhou Novaken Pharmaceutical possesses a standalone experimental building of nearly 10,000 square meters, equipped with complete facilities for the R&D of both common and high-end pharmaceutical formulations. It can provide customers with comprehensive, high-quality R&D services, covering pre-formulation studies, formulation R&D, process R&D, quality research, stability testing, and technical support for FDA and EU submissions, with extensive experience in formulation R&D and consistency evaluations according to US and EU ANDA standards.